Summary

The global market for POC HbA1C Testing was estimated to be worth US$ 550 million in 2024 and is forecast to a readjusted size of US$ 984 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes. HbA1c is your average blood glucose (sugar) levels for the last two to three months. The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels. In this report, we mainly study the devices for POC HbA1C Testing without services.
Market Drivers:
The growing prevalence of diabetes worldwide is a key driver for the POC HbA1c testing market. As the number of diabetic and prediabetic patients continues to rise, there is an increasing need for quick and efficient monitoring solutions to manage blood sugar levels effectively. POC HbA1c testing provides immediate results, allowing for real-time clinical decision-making and reducing patient dependence on centralized laboratories. Additionally, advancements in technology have led to the development of highly accurate, portable, and user-friendly devices, expanding their adoption in hospitals, clinics, and even home settings. Government initiatives promoting early diabetes detection and personalized treatment plans further boost market growth.
Market Challenges:
Despite its advantages, POC HbA1c testing faces several challenges, including high costs and reimbursement limitations in some healthcare systems, which may hinder widespread adoption. Additionally, variations in accuracy and standardization among different POC devices pose concerns regarding result reliability, especially when compared to laboratory-based testing. Regulatory approvals and compliance with stringent quality standards also create barriers for manufacturers entering new markets. Furthermore, lack of awareness and limited access to POC testing in certain developing regions restricts its potential reach, requiring further investments in education and healthcare infrastructure.
This report aims to provide a comprehensive presentation of the global market for POC HbA1C Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of POC HbA1C Testing by region & country, by Type, and by Application.
The POC HbA1C Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POC HbA1C Testing.
Market Segmentation
By Company
Abbott
Siemens Healthineers
Roche
Bio-Rad
GREEN CROSS MEDIS
Trinity Biotech
HUMAN Diagnostics
Sinocare (PTS Diagnostics)
Erba Diagnostics
EKF Diagnostics
OSANG Healthcare
SD Biosensor
Aidian
Boditech Med
i-SENS
Segment by Type
Immunoassay
Boronate Affinity
Others
Segment by Application
Hospital and Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of POC HbA1C Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of POC HbA1C Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of POC HbA1C Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 POC HbA1C Testing Product Introduction
1.2 Global POC HbA1C Testing Market Size Forecast (2020-2031)
1.3 POC HbA1C Testing Market Trends & Drivers
1.3.1 POC HbA1C Testing Industry Trends
1.3.2 POC HbA1C Testing Market Drivers & Opportunity
1.3.3 POC HbA1C Testing Market Challenges
1.3.4 POC HbA1C Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global POC HbA1C Testing Players Revenue Ranking (2024)
2.2 Global POC HbA1C Testing Revenue by Company (2020-2025)
2.3 Key Companies POC HbA1C Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies POC HbA1C Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of POC HbA1C Testing
2.6 POC HbA1C Testing Market Competitive Analysis
2.6.1 POC HbA1C Testing Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by POC HbA1C Testing Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POC HbA1C Testing as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Immunoassay
3.1.2 Boronate Affinity
3.1.3 Others
3.2 Global POC HbA1C Testing Sales Value by Type
3.2.1 Global POC HbA1C Testing Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global POC HbA1C Testing Sales Value, by Type (2020-2031)
3.2.3 Global POC HbA1C Testing Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital and Clinics
4.1.2 Diagnostic Laboratories
4.1.3 Others
4.2 Global POC HbA1C Testing Sales Value by Application
4.2.1 Global POC HbA1C Testing Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global POC HbA1C Testing Sales Value, by Application (2020-2031)
4.2.3 Global POC HbA1C Testing Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global POC HbA1C Testing Sales Value by Region
5.1.1 Global POC HbA1C Testing Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global POC HbA1C Testing Sales Value by Region (2020-2025)
5.1.3 Global POC HbA1C Testing Sales Value by Region (2026-2031)
5.1.4 Global POC HbA1C Testing Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America POC HbA1C Testing Sales Value, 2020-2031
5.2.2 North America POC HbA1C Testing Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe POC HbA1C Testing Sales Value, 2020-2031
5.3.2 Europe POC HbA1C Testing Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific POC HbA1C Testing Sales Value, 2020-2031
5.4.2 Asia Pacific POC HbA1C Testing Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America POC HbA1C Testing Sales Value, 2020-2031
5.5.2 South America POC HbA1C Testing Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa POC HbA1C Testing Sales Value, 2020-2031
5.6.2 Middle East & Africa POC HbA1C Testing Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions POC HbA1C Testing Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions POC HbA1C Testing Sales Value, 2020-2031
6.3 United States
6.3.1 United States POC HbA1C Testing Sales Value, 2020-2031
6.3.2 United States POC HbA1C Testing Sales Value by Type (%), 2024 VS 2031
6.3.3 United States POC HbA1C Testing Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe POC HbA1C Testing Sales Value, 2020-2031
6.4.2 Europe POC HbA1C Testing Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe POC HbA1C Testing Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China POC HbA1C Testing Sales Value, 2020-2031
6.5.2 China POC HbA1C Testing Sales Value by Type (%), 2024 VS 2031
6.5.3 China POC HbA1C Testing Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan POC HbA1C Testing Sales Value, 2020-2031
6.6.2 Japan POC HbA1C Testing Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan POC HbA1C Testing Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea POC HbA1C Testing Sales Value, 2020-2031
6.7.2 South Korea POC HbA1C Testing Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea POC HbA1C Testing Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia POC HbA1C Testing Sales Value, 2020-2031
6.8.2 Southeast Asia POC HbA1C Testing Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia POC HbA1C Testing Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India POC HbA1C Testing Sales Value, 2020-2031
6.9.2 India POC HbA1C Testing Sales Value by Type (%), 2024 VS 2031
6.9.3 India POC HbA1C Testing Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Profile
7.1.2 Abbott Main Business
7.1.3 Abbott POC HbA1C Testing Products, Services and Solutions
7.1.4 Abbott POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.1.5 Abbott Recent Developments
7.2 Siemens Healthineers
7.2.1 Siemens Healthineers Profile
7.2.2 Siemens Healthineers Main Business
7.2.3 Siemens Healthineers POC HbA1C Testing Products, Services and Solutions
7.2.4 Siemens Healthineers POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.2.5 Siemens Healthineers Recent Developments
7.3 Roche
7.3.1 Roche Profile
7.3.2 Roche Main Business
7.3.3 Roche POC HbA1C Testing Products, Services and Solutions
7.3.4 Roche POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.3.5 Roche Recent Developments
7.4 Bio-Rad
7.4.1 Bio-Rad Profile
7.4.2 Bio-Rad Main Business
7.4.3 Bio-Rad POC HbA1C Testing Products, Services and Solutions
7.4.4 Bio-Rad POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.4.5 Bio-Rad Recent Developments
7.5 GREEN CROSS MEDIS
7.5.1 GREEN CROSS MEDIS Profile
7.5.2 GREEN CROSS MEDIS Main Business
7.5.3 GREEN CROSS MEDIS POC HbA1C Testing Products, Services and Solutions
7.5.4 GREEN CROSS MEDIS POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.5.5 GREEN CROSS MEDIS Recent Developments
7.6 Trinity Biotech
7.6.1 Trinity Biotech Profile
7.6.2 Trinity Biotech Main Business
7.6.3 Trinity Biotech POC HbA1C Testing Products, Services and Solutions
7.6.4 Trinity Biotech POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.6.5 Trinity Biotech Recent Developments
7.7 HUMAN Diagnostics
7.7.1 HUMAN Diagnostics Profile
7.7.2 HUMAN Diagnostics Main Business
7.7.3 HUMAN Diagnostics POC HbA1C Testing Products, Services and Solutions
7.7.4 HUMAN Diagnostics POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.7.5 HUMAN Diagnostics Recent Developments
7.8 Sinocare (PTS Diagnostics)
7.8.1 Sinocare (PTS Diagnostics) Profile
7.8.2 Sinocare (PTS Diagnostics) Main Business
7.8.3 Sinocare (PTS Diagnostics) POC HbA1C Testing Products, Services and Solutions
7.8.4 Sinocare (PTS Diagnostics) POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.8.5 Sinocare (PTS Diagnostics) Recent Developments
7.9 Erba Diagnostics
7.9.1 Erba Diagnostics Profile
7.9.2 Erba Diagnostics Main Business
7.9.3 Erba Diagnostics POC HbA1C Testing Products, Services and Solutions
7.9.4 Erba Diagnostics POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.9.5 Erba Diagnostics Recent Developments
7.10 EKF Diagnostics
7.10.1 EKF Diagnostics Profile
7.10.2 EKF Diagnostics Main Business
7.10.3 EKF Diagnostics POC HbA1C Testing Products, Services and Solutions
7.10.4 EKF Diagnostics POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.10.5 EKF Diagnostics Recent Developments
7.11 OSANG Healthcare
7.11.1 OSANG Healthcare Profile
7.11.2 OSANG Healthcare Main Business
7.11.3 OSANG Healthcare POC HbA1C Testing Products, Services and Solutions
7.11.4 OSANG Healthcare POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.11.5 OSANG Healthcare Recent Developments
7.12 SD Biosensor
7.12.1 SD Biosensor Profile
7.12.2 SD Biosensor Main Business
7.12.3 SD Biosensor POC HbA1C Testing Products, Services and Solutions
7.12.4 SD Biosensor POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.12.5 SD Biosensor Recent Developments
7.13 Aidian
7.13.1 Aidian Profile
7.13.2 Aidian Main Business
7.13.3 Aidian POC HbA1C Testing Products, Services and Solutions
7.13.4 Aidian POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.13.5 Aidian Recent Developments
7.14 Boditech Med
7.14.1 Boditech Med Profile
7.14.2 Boditech Med Main Business
7.14.3 Boditech Med POC HbA1C Testing Products, Services and Solutions
7.14.4 Boditech Med POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.14.5 Boditech Med Recent Developments
7.15 i-SENS
7.15.1 i-SENS Profile
7.15.2 i-SENS Main Business
7.15.3 i-SENS POC HbA1C Testing Products, Services and Solutions
7.15.4 i-SENS POC HbA1C Testing Revenue (US$ Million) & (2020-2025)
7.15.5 i-SENS Recent Developments
8 Industry Chain Analysis
8.1 POC HbA1C Testing Industrial Chain
8.2 POC HbA1C Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 POC HbA1C Testing Sales Model
8.5.2 Sales Channel
8.5.3 POC HbA1C Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer